represented 2.1% of this cohort, mid-volume practitioners represented 9.6%, and low-volume vascular practitioners represented 88.3%. The percentage of mid-and high-volume vascular practitioners increased significantly (5.8% to 9.1% and 0.8% to 2.3%, respectively; P < .0001), as did the number of patients they treated (25,849 to 31,602 and 1561 to 6207, respectively; P < .0001). Low-volume interventionalists saw a significant decrease in both the number of patients treated and the percentage of their overall cohort size (51,796 to 33,771 and 93.4% to 87.8%, respectively; P < .001). Table I displays the outcome variables by vascular volume and  associated significance values. Table II shows the multivariate regression analysis for the outcome variables. High-volume vascular surgeons had a 27% decreased odds of in-hospital mortality and 11% decreased odds of complication compared with low-volume practitioners when performing vascular procedures (P < .001). The average length of stay and total hospital charges for patients treated by high-volume vascular surgeons were 1.5 days and $23,016 less than that of low-volume practitioners (P < .001).
Objective: Frailty is a pivotal part of the preoperative evaluation and therapeutic decision-making in older adults with peripheral arterial disease (PAD) because frailty is related to postoperative morbidity and mortality. However, performance-based frailty scales may not be feasible in this mobility-impaired population. The objective of this study was to determine the prevalence of frailty in this population and to compare the incremental value of six questionnaire-based frailty scales to predict poor outcomes after interventions for PAD.
Methods: Frailty Assessment in Lower Extremity Arterial Disease (FRAILED) was a prospective cohort study including two centers in Montreal, Canada, designed to examine frailty in patients with PAD. Consecutive patients undergoing endovascular or open interventions for PAD (Rutherford class 3 or higher) were enrolled. The prevalence of frailty was assessed in all patients using the following frailty scales: Edmonton Frailty Scale, FRAIL scale, Groningen Frailty Indicator (GFI), modified Frailty Index, Multidimensional Prognostic Index, and modified Essential Frailty Toolset (mEFT). The primary outcome was a composite of all-cause mortality and morbidity, including major vascular complication requiring surgical or medical intervention.
Results: The cohort consisted of 149 older adults with a mean age of 70.5 6 10.8 years. Patients with claudication and critical ischemia accounted for 40% (n ¼ 60) and 60% (n ¼ 89), respectively. Fifty-four percent (n ¼ 81) received endovascular interventions, and 46% (n ¼ 68) received open interventions. Depending on the scale, the prevalence of frailty ranged from 37% to 70%. The incidence of all-cause mortality was 6.3% in the cohort during a median follow-up of 1.3 years. After adjusting for age, sex, predicted operative risk with the Revised Cardiac Risk Index, diagnosis, and procedure type, the frailty scales with the greatest incremental value for mortality and morbidity were found to be the GFI (standardized adjusted odds ratio, 3.22; 95% confidence interval, 1.32-8.86; Bayesian information criterion, 88.7) and the mEFT (standardized adjusted odds ratio, 1.99; 95% confidence interval, 1.01-3.97; Bayesian information criterion, 93.2). The four other frailty scales were not statistically significant in the multivariable logistic models.
Conclusions: The prevalence of frailty and the prognostic impact of frailty varied by the scale used. The GFI and mEFT performed well and were most predictive of mortality and morbidity in patients with PAD undergoing interventions. The GFI and mEFT would be more appropriate to use in clinical practice in assessing frailty in patients with PAD. Objective: Advancement in academic appointments is multifactorial. Our objectives were to characterize the current landscape of academic appointments in vascular surgery and to investigate what factors, particularly publications, influenced academic promotion.
Methods: Academic vascular surgeons at an Accreditation Council for Graduate Medical Education vascular training program or at a primary site of a U.S. allopathic medical school were included. Those with qualified titles, such as adjunct or a clinical prefix, were excluded. Sex, education, region, board certification, and affiliation details were recorded. Web of Science was queried for number of publications, number of first or last author publications, and h-index. The h-index is a personal impact factor defined as x number of publications cited at least x number of times. Univariable and multivariable analyses were completed to predict academic appointments and as division chief.
Results: There were 642 vascular surgeons who met criteria: 297 (46.3%) assistant professors, 150 (30.4%) associate professors, and 195 (30.4%) professors. There were 15.1% division chiefs and 1.6% chairs of surgery; 83.2% were male. Region distribution was 33.5% Northeast, 32.6% Southern, 20.1% Central, and 13.9% Western. Mean number of publications was 13.7 6 15.4 for assistant, 33.9 6 28.8 for associate, and 86.8 6 63.6 for professor (P < .001). The mean number of first or last author publications was Conclusions: Total number of publications was independently associated with promotion from assistant to associate professor, with number of first or last author publications particularly important for professor. The h-index was not an independent predictor for promotion in academic appointment but was predictive for appointment as division chief. This study provides relevant data for promotional guidance in academic vascular surgery. Objective: The objective of this study was to analyze outcomes of fenestrated-branched endovascular aneurysm repair for treatment of postdissection and degenerative thoracoabdominal aortic aneurysms (TAAAs).
Methods: We reviewed the clinical data of 221 patients with extent I to III TAAAs enrolled in seven prospective physician-sponsored investigational device exemption studies from 2014 to 2017. All patients had manufactured off-the-shelf and patient-specific fenestrated-branched stent grafts (Fig) used to target 790 renal-mesenteric arteries with a mean of 3.9 vessels per patient. End points were mortality, major adverse events (any cause mortality, stroke, paraplegia, acute kidney injury, myocardial infarction, respiratory failure, bowel ischemia, and estimated blood loss >1 L), technical success, target artery patency, target artery instability (occlusion or stenosis, endoleak, rupture, or death), and secondary interventions.
Results: There were 46 patients (21%) treated for postdissection TAAAs and 175 patients (79%) who had degenerative TAAAs. Postdissection patients were significantly (P < .05) younger (67 6 10 vs 74 6 8 years), were more often male (76% vs 52%), and had more staged aortic repairs (85% vs 63%) and larger renal (6.2 6 1.2 mm vs 5.4 6 0.9 mm) and mesenteric (8.8 6 1.6 mm vs 7.6 6 1.2 mm) target artery diameters. There was no difference (P > .05) in aneurysm diameter (66 6 13 mm vs 67 6 11 mm), extent I or II TAAA classification (61% vs 50%), and length of supraceliac aortic coverage (22 6 9 cm vs 20 6 10 cm) between postdissection and degenerative TAAA patients, respectively. Patient-specific stent grafts (91% vs 81%), preloaded guidewire systems (81% vs 48%), and fenestrations as opposed to branches (61% vs 35%) were used more frequently to treat postdissection TAAAs (P < .05). Technical success was 100% for postdissection and 96% for degenerative TAAAs (P ¼ .24). At 30 days, there was no difference in mortality (2% each), major adverse events (26% postdissection, 22% degenerative), spinal cord injury (2% postdissection, 10% degenerative), paraplegia (0% postdissection, 6% 
